Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease

BACKGROUND: Steroid resistant nephrotic syndrome (SRNS), while uncommon in children, is associated with significant morbidity. Calcineurin inhibitors (CNIs) remain the first line recommended therapy for children with non-genetic forms of SRNS, but some children fail to respond to them. Intravenous (...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Maha, Kale, Arundhati, Butani, Lavjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628458/
https://www.ncbi.nlm.nih.gov/pubmed/34839817
http://dx.doi.org/10.1186/s12882-021-02605-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628458/
https://www.ncbi.nlm.nih.gov/pubmed/34839817
http://dx.doi.org/10.1186/s12882-021-02605-6

Ejemplares similares